YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Genetics of Fatty Liver Disease in Children

Completed

Conditions: Non Alcoholic Fatty Liver Disease

Interventions: Other: ogtt
Other: genotyping
Other: abdominal and liver magnetic resonance imaging
Other: stool sample
Other: liver biopsy

First Posted Date: 2013-10-21

Last Posted Date: 2017-12-08

Lead Sponsor: Yale University

Target Recruit Count: 381

Registration Number: NCT01966627

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents

Not Applicable

Completed

Conditions: Disruptive Behavior
Anger
Irritability
Noncompliance
Aggression

Interventions: Behavioral: Supportive Psychotherapy (SPT)
Behavioral: Cognitive-Behavioral Therapy for Anger and Aggression

First Posted Date: 2013-10-18

Last Posted Date: 2023-11-18

Lead Sponsor: Yale University

Target Recruit Count: 101

Registration Number: NCT01965184

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

CHG Dressings in Children With Central Lines

Not Applicable

Terminated

Conditions: Children With Central Venous Access

Interventions: Other: Tegaderm CHG clear dressing
Other: Standard clear Tegaderm dressing

First Posted Date: 2013-10-07

Last Posted Date: 2016-05-13

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT01955226

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?

Early Phase 1

Terminated

Conditions: Type 1 Diabetes

Interventions: Device: Continuous glucose sensor
Device: Insupatch

First Posted Date: 2013-10-01

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 11

Registration Number: NCT01954459

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy

Early Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Device: ePID closed loop system
Drug: Lispro-PH20
Drug: hyaluronidase

First Posted Date: 2013-09-18

Last Posted Date: 2022-05-24

Lead Sponsor: Yale University

Target Recruit Count: 13

Registration Number: NCT01945099

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

The Development of a Domestic Violence Perpetrator Collusion Measurement Tool

Not Applicable

Completed

Conditions: Intimate Partner Violence (IPV)

First Posted Date: 2013-09-16

Last Posted Date: 2023-08-30

Lead Sponsor: Yale University

Target Recruit Count: 72

Registration Number: NCT01942616

Locations: 🇺🇸
Michigan State University, East Lansing, Michigan, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Loyola University New Orleans, New Orleans, Louisiana, United States

and more 1 locations

Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.

Phase 2

Completed

Conditions: Restless Leg Syndrome

Interventions: Drug: Placebo
Drug: incobotulinumtoxinA

First Posted Date: 2013-08-29

Last Posted Date: 2016-03-21

Lead Sponsor: Yale University

Target Recruit Count: 24

Registration Number: NCT01931878

Locations: 🇺🇸
Yale Physcian Building, New Haven, Connecticut, United States

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Phase 2

Terminated

Conditions: Pain

Interventions: Drug: IncobotulinumtoxinA

First Posted Date: 2013-08-29

Last Posted Date: 2015-12-31

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT01931865

Locations: 🇺🇸
Yale Physician Building, New Haven, Connecticut, United States

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

Phase 2

Completed

Conditions: Type I Diabetes

Interventions: Drug: Placebo
Drug: Exenatide (Bydureon®)

First Posted Date: 2013-08-23

Last Posted Date: 2020-03-19

Lead Sponsor: Yale University

Target Recruit Count: 79

Registration Number: NCT01928329

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

and more 5 locations

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

Completed

Conditions: Atypical Ductal Hyperplasia (ADH) of the Breast

First Posted Date: 2013-08-19

Last Posted Date: 2019-01-28

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT01925586

Locations: 🇺🇸
Yale University & Smilow Breast Center at Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy